List of Tables
Summary Table: Global Market for Cardiovascular Devices, by Region, Through 2030
Table 1: Cardiovascular Diseases: Modifiable Risk Factors
Table 2: Global: Annual Cardiac Surgical Volumes per 100,000 Population Per Year
Table 3: Cost of Cardiovascular Surgery, by Country, 2025
Table 4: Porter’s Five Forces Analysis: Overview
Table 5: Global Cardiovascular Disease: Prevalence and Deaths, 2023
Table 6: Advantages of Remote Patient Monitoring
Table 7: Cardiovascular Care Programs Driving Value-Based Outcomes and Cost Efficiency
Table 8: Complications Associated with Implantable Devices
Table 9: FDA Regulatory Pathways and Cardiovascular Device Classification Overview
Table 10: EU Medical Device Regulatory Pathway
Table 11: Other Region: Cardiovascular Regulatory Landscape
Table 12: List of Wearable Cardiac Devices
Table 13: Total Artificial Heart, Company Comparison, 2026
Table 14: AI in Cardiology: Application
Table 15: Patents, by Top Applicant, 2022-2025
Table 16: Patents, by Top Owner, 2022-2025
Table 17: Patents, by Jurisdiction, 2022-2025
Table 18: Global Market for Cardiovascular Devices Market, by Product, Through 2030
Table 19: TAVR Systems, by Company
Table 20: TMVR Systems, by Company
Table 21: Major Catheters in Interventional Cardiology
Table 22: Type of Cardiovascular Stent
Table 23: Advances in Drug-Eluting Stents
Table 24: Global Market for Interventional Cardiology, by Type, Through 2030
Table 25: Pacemaker, by Company
Table 26: Advances in Pacemakers
Table 27: CRT Devices, by Company
Table 28: ICD Devices, by Company
Table 29: Global Market for Cardiac Rhythm Management, by Type, Through 2030
Table 30: Different Types of ECG
Table 31: ECG Products, by Type
Table 32: Different Types of Echocardiographs
Table 33: Echocardiograph, by Company
Table 34: Global Market for Diagnostics and Monitoring, by Type, Through 2030
Table 35: Ventricular Assist Device, by Company
Table 36: Intra-Aortic Balloon Pump, by Company
Table 37: Global Market for Cardiac Assist Devices, by Type, Through 2030
Table 38: Global Market for Electrophysiology, by Type, Through 2030
Table 39: Global Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 40: Global Market for Cardiovascular Devices, by End User, Through 2030
Table 41: Global Market for Cardiovascular Devices, by Region, Through 2030
Table 42: North American Market for Cardiovascular Devices, by Country, Through 2030
Table 43: North American Market for Cardiovascular Devices, by Product, Through 2030
Table 44: North American Market for Interventional Cardiology, by Type, Through 2030
Table 45: North American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 46: North American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 47: North American Market for Cardiac Assist Devices, by Type, Through 2030
Table 48: North American Market for Electrophysiology, by Type, Through 2030
Table 49: North American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 50: North American Market for Cardiovascular Devices, by End User, Through 2030
Table 51: European Market for Cardiovascular Devices, by Country, Through 2030
Table 52: European Market for Cardiovascular Devices, by Product, Through 2030
Table 53: European Market for Interventional Cardiology, by Type, Through 2030
Table 54: European Market for Cardiac Rhythm Management, by Type, Through 2030
Table 55: European Market for Diagnostics and Monitoring, by Type, Through 2030
Table 56: European Market for Cardiac Assist Devices, by Type, Through 2030
Table 57: European Market for Electrophysiology, by Type, Through 2030
Table 58: European Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 59: European Market for Cardiovascular Devices, by End User, Through 2030
Table 60: Asia-Pacific Market for Cardiovascular Devices, by Country, Through 2030
Table 61: Asia-Pacific Market for Cardiovascular Devices, by Product, Through 2030
Table 62: Asia-Pacific Market for Interventional Cardiology, by Type, Through 2030
Table 63: Asia-Pacific Market for Cardiac Rhythm Management, by Type, Through 2030
Table 64: Asia-Pacific Market for Diagnostics and Monitoring, by Type, Through 2030
Table 65: Asia-Pacific Market for Cardiac Assist Devices, by Type, Through 2030
Table 66: Asia-Pacific Market for Electrophysiology, by Type, Through 2030
Table 67: Asia-Pacific Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 68: Asia-Pacific Market for Cardiovascular Devices, by End User, Through 2030
Table 69: South American Market for Cardiovascular Devices, by Product, Through 2030
Table 70: South American Market for Interventional Cardiology, by Type, Through 2030
Table 71: South American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 72: South American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 73: South American Market for Cardiac Assist Devices, by Type, Through 2030
Table 74: South American Market for Electrophysiology, by Type, Through 2030
Table 75: South American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 76: South American Market for Cardiovascular Devices, by End User, Through 2030
Table 77: MEA Market for Cardiovascular Devices, by Product, Through 2030
Table 78: MEA Market for Interventional Cardiology, by Type, Through 2030
Table 79: MEA Market for Cardiac Rhythm Management, by Type, Through 2030
Table 80: MEA Market for Diagnostics and Monitoring, by Type, Through 2030
Table 81: MEA Market for Cardiac Assist Devices, by Type, Through 2030
Table 82: MEA Market for Electrophysiology, by Type, Through 2030
Table 83: MEA Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 84: MEA Market for Cardiovascular Devices, by End User, Through 2030
Table 85: Global Market Share Analysis for Cardiovascular Devices, by Company, 2024
Table 86: Cardiovascular Devices: Recent Strategic Developments, 2024-2026
Table 87: Report Information Sources
Table 88: Abbreviations Used in the Cardiovascular Devices Market Report
Table 89: Abbott: Company Snapshot
Table 90: Abbott: Financial Performance, FY 2023 and 2024
Table 91: Abbott: Product Portfolio
Table 92: Abbott: News/Key Developments, 2023-2025
Table 93: Baxter: Company Snapshot
Table 94: Baxter: Financial Performance, FY 2023 and 2024
Table 95: Baxter: Product Portfolio
Table 96: B. Braun SE: Company Snapshot
Table 97: B. Braun SE: Financial Performance, FY 2023 and 2024
Table 98: B. Braun SE: Product Portfolio
Table 99: Biotronik: Company Snapshot
Table 100: Biotronik: Product Portfolio
Table 101: Biotronik: News/Key Developments, 2023-2025
Table 102: Boston Scientific Corp.: Company Snapshot
Table 103: Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 104: Boston Scientific Corp.: Product Portfolio
Table 105: Boston Scientific Corp.: News/Key Developments, 2024-2026
Table 106: BPL Medical Technologies: Company Snapshot
Table 107: BPL Medical Technologies: Product Portfolio
Table 108: Cook: Company Snapshot
Table 109: Cook: Product Portfolio
Table 110: Edwards Lifesciences Corp.: Company Snapshot
Table 111: Edwards Lifesciences Corp.: Financial Performance, FY 2023 and 2024
Table 112: Edwards Lifesciences Corp.: Product Portfolio
Table 113: Edwards Lifesciences Corp.: News/Key Developments, 2024-2025
Table 114: GE HealthCare: Company Snapshot
Table 115: GE HealthCare: Financial Performance, FY 2023 and 2024
Table 116: GE HealthCare: Product Portfolio
Table 117: GE HealthCare: News/Key Developments, 2023
Table 118: Johnson & Johnson: Company Snapshot
Table 119: Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 120: Johnson & Johnson: Product Portfolio
Table 121: Johnson & Johnson: News/Key Developments, 2023-2025
Table 122: Koninklijke Philips N.V.: Company Snapshot
Table 123: Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 124: Koninklijke Philips N.V.: Product Portfolio
Table 125: Medtronic: Company Snapshot
Table 126: Medtronic: Financial Performance, FY 2023 and 2024
Table 127: Medtronic: Product Portfolio
Table 128: Medtronic: News/Key Developments, 2023-2025
Table 129: Nihon Kohden Corp.: Company Snapshot
Table 130: Nihon Kohden Corp.: Financial Performance, FY 2023 and 2024
Table 131: Nihon Kohden Corp.: Product Portfolio
Table 132: Nihon Kohden Corp.: News/Key Developments, 2024
Table 133: Siemens Healthineers AG: Company Snapshot
Table 134: Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 135: Siemens Healthineers AG: Product Portfolio
Table 136: Siemens Healthineers AG: News/Key Developments, 2023
Table 137: Terumo Corp.: Company Snapshot
Table 138: Terumo Corp.: Financial Performance, FY 2023 and 2024
Table 139: Terumo Corp.: Product Portfolio
Table 140: Terumo Corp.: News/Key Developments, 2025
Table 141: List of a Few Emerging Start-Ups/ Market Disruptors
List of Figures
Summary Figure: Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 1: Heart Bypass Surgery Cost Structure, India, 2025
Figure 2: Porter’s Five Forces Analysis of the Technologies for Cardiovascular Devices Market
Figure 3: Snapshot of Market Dynamics of Cardiovascular Devices
Figure 4: Advantages of Minimally Invasive Procedures in Cardiovascular Treatment
Figure 5: CARDIOLOGY: Remote Patient Monitoring Solutions
Figure 6: Challenges in Cardiovascular Device Manufacturing
Figure 7: Emerging Trends/Technologies in the Cardiovascular Devices Market
Figure 8: Patents Granted, by Year, 2022-2025
Figure 9: Global Market Shares of Cardiovascular Devices, by Product, 2024
Figure 10: Global Market Shares of Cardiovascular Devices, by End User, 2024
Figure 11: Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 12: North American Market Shares of Cardiovascular Devices, by Country, 2024
Figure 13: European Market Shares of Cardiovascular Devices, by Country, 2024
Figure 14: Asia-Pacific Market Shares of Cardiovascular Devices, by Country, 2024
Figure 15: Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 16: Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 17: Baxter: Revenue Shares, by Business Unit, FY 2024
Figure 18: Baxter: Revenue Shares, by Country/Region, FY 2024
Figure 19: B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 20: B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 21: Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 22: Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 23: Edwards Lifesciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 24: Edwards Lifesciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 25: GE HealthCare: Revenue Shares, by Business Unit, FY 2024
Figure 26: GE HealthCare: Revenue Shares, by Country/Region, FY 2024
Figure 27: Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
Figure 28: Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
Figure 29: Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2024
Figure 30: Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2024
Figure 31: Medtronic: Revenue Shares, by Business Unit, FY 2024
Figure 32: Medtronic: Revenue Shares, by Region/Country, FY 2024
Figure 33: Nihon Kohden Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 34: Nihon Kohden Corp.: Revenue Shares, by Region/Country, FY 2024
Figure 35: Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 36: Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
Figure 37: Terumo Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 38: Terumo Corp.: Revenue Shares, by Country/Region, FY 2024
